Attention! If your child is very smiley but does not speak, if he or she has developmental delays, balance and movement difficulties, trouble falling asleep or wakes up multiple times during the night, if he or she has intestinal constipation, stomach reflux, strabismus, and seizures: reach out for your family doctor/pediatritian, and ask about Angelman syndrome.
Your doctor may order tests and refer you to other specialists, as well as provide guidance on appropriate stimulation, which should be started as early as possible!
Providing early stimulation for your child is very important!
Seek medical advice!
Launched on International Angelman Syndrome Day, February 15, 2024, the "Campaign for Early Diagnosis" - a GAMAS Initiative - quickly went viral on Instagram on our profile @gabi.gamas.
Days after its launch, the video had already been organically reproduced over 40,000 times on the 12 partner profiles of the GAMAS Initiative where it was published, including Angelman families, clinics, pediatricians, and therapists. Additionally, the video was widely circulated on WhatsApp and was heavily reposted in Stories by followers of the GAMAS Initiative and its partners. This outstanding reach was entirely organic, with no paid advertising strategies adopted on Instagram.
The goal of the Campaign is to alert about the symptoms of the syndrome and encourage parents to seek medical advice as quickly as possible.
Contraindicated medications
Early intervention
Genetic Counseling
Epilepsy is present in 80% of individuals affected by Angelman syndrome, making it crucial to properly manage epileptic seizures. Some medications traditionally used to treat epilepsy are contraindicated for patients with Angelman syndrome, such as:
Carbamazepine,
Vigabatrin,
Phenobarbital.
These medications can exacerbate epilepsy in people with Angelman syndrome.
Medications like primidone and phenytoin, less prescribed nowadays, are also contraindicated for patients with Angelman syndrome.
Moreover, medications based on valproic acid (such as Depakene, Depakote, and Valpakine), although effective in controlling epilepsy cases, have been associated with significant motor side effects that are particularly concerning in patients with Angelman Syndrome, where motor difficulties are naturally present.
Early diagnosis is a way to minimize patient exposure to the risk of antiepileptic drugs contraindicated for Angelman syndrome.
O artigo "Abordagem Multidisciplinar e Consenso para Estabelecer os Padrões de Tratamento para Síndrome de Angelman" cita:
"Os anticonvulsivantes que provavelmente oferecem benefícios com efeitos adversos limitados incluem clobazam, levetiracetam e clonazepam. A recomendação de consenso é tratar com clobazam ou levetiracetam como terapia de primeira linha e considerar intervenção dietética, incluindo uma dieta cetogênica ou terapia de baixo índice glicêmico".
O artigo também comenta que em situações emergenciais de crises epilépticas prolongadas utiliza-se supositório de diazepam ou midazolan intranasal (o último não é disponível no Brasil).
Early intervention is essential for the cognitive and motor development of a child with Angelman syndrome. It is crucial to optimize the neuroplasticity window of early childhood. Therapies help to maximize functional abilities and quality of life, promoting a more holistic and adaptive development of the child. Talk to your pediatrician to explore the possibility of referring your child to early intervention therapies such as physical therapy (PT), occupational therapy (OT), hippotherapy, speech therapy, augmentative and alternative communication (AAC), among others.
When a woman silently carries the genetic alteration — meaning she carries the alteration but does not manifest the symptoms of the syndrome — there is a 50% probability of transmitting it to her children. Although rare, there are cases where Angelman Syndrome can be inherited. Most hereditary cases are associated with mutation genotypes and defects in the imprinting center.
Therefore, early genetic diagnosis is crucial, not only to confirm the presence of Angelman Syndrome in the individual but also to provide appropriate genetic counseling before a next pregnancy. This counseling is essential to guide family planning decisions, allowing families to make informed choices about having more children, assessing the risks involved, and considering available options such as in vitro fertilization, which, combined with pre-implantation genetic diagnosis, offers a possibility to prevent the transmission of the condition to the next generation.
To learn more about aspects of heredity in Angelman syndrome, click here.